2024 Agenda

The forum will highlight recent advances, current trends, and innovations that will shape the future of ophthalmology.

Thursday, June 20, 2024 – INVITE ONLY EVENTS

3:00 – 4:30 pm PST


Tier 1 Sponsor Advisory Board Opportunity (Sold Out)

4:30 – 5:30 pm PST


OWL Socal Chapter Meeting

4:30 – 5:30 pm PST


Partnership Pursuit: Physician & Entrepreneur Reception 

This is a unique opportunity for you to meet these innovative entrepreneurs and determine if there is a mutually beneficial fit and interest. These companies will be within the medical industry, not necessarily ophthalmic specific, and provide a good opportunity to contribute your diverse perspective.

5:30 – 7:00 pm PST


Welcome Reception
Friday, June 21, 2024

6:30 – 8:00 am PST


Tier 1 Sponsor Advisory Board Opportunity (Sold Out)

7:00 – 8:00 am PST


Registration, Exhibits & Continental Breakfast

Network with colleagues! You can also set appointments within our virtual platform or take part in a networking session catered to your interests.

8:00 – 8:10 am PST


Opening Comments

Octane CEO, Bill Carpou will reflect on the impact of ophthalmology in Southern California and beyond.

Bill Carpou, CEO, Octane

8:10 – 8:35 am PST

State of the Ophthalmic Industry Report

Hear from an industry-leading expert on eyecare’s current and future investment trends and growth opportunities.

Sergio Rossi, Managing Director & Partner, Boston Consulting Group

8:35 – 9:05 am PST


Keynote Interview

Euan Thomson, PhD, President of Ophthalmic Devices and Head of Digital Business Unit, Carl Zeiss Meditec Inc.

Jim Mazzo, Executive Chairman, Neurotech, Co-Founder, Octane

9:05 – 9:35 am PST


Innovations in the Posterior Segment

Leading Posterior Segment surgeons will present their favorite new and upcoming technologies. An interactive panel discussion will follow the presentations.

Bob Avery, MD, California Retina Consultants

Doug Faunce, Executive Director, External Disease, AbbVie

Beth Marsh, Vice President of Sales & Marketing – Ophthalmology, Apellis Pharmaceuticals, Inc.

Aaron Osborne, Executive Director Ophthalmology, USMA, Genentech, Inc.

9:35 – 10:05 am PST


Modern Practice-the Latest in Anterior Segment Innovations

Leading Anterior Segment surgeons will present the new and future technologies they are most excited about for their practices. An interactive panel discussion will follow the presentations.

Ehsan Sadri, MD, FACS, CEO and Founder, Visionary Eye Institute (Moderator)

Alex Lopez, Chief Commercial Officer, Ace Vision Group

Lisa Nijm, MD, JD, Founder and Medical Director, Warrenville Eyecare and LASIK

Adam Szaronos, President & CEO, Trukera Medical

Dagny Zhu, MD, Medical Director and Partner, NVISION Eye Centers 

10:05 – 10:35 am PST


Innovations and Applications in Genetic Engineering and Cell Transplantation

The future of medicine is here! This cutting-edge panel will feature leading experts in genetic engineering and cell transportation. The panelists will discuss which technologies are at the forefront and where the industry is headed in this exciting space.

Baruch Kuppermann, MD, PhD, Steinert Endowed Professor, Chair, Department of Ophthalmology, Director, Gavin Herbert Eye Institute, University of California, Irvine (Moderator)

Greg Kunst, Chief Executive Officer, Aurion Biotech

Jeffrey L. Goldberg, MD, PhD, Co-founder and Director, Board of Managers, Emmecell

John Pollack, MD, Chief Medical Officer, jCyte, Inc.

Richard Small, Chief Executive Officer & Board of Directors, Neurotech Pharmaceuticals, Inc.


10:35 – 11:05 am PST


Break: Networking, Exhibits & Coffee

11:05 am – 11:25 pm PST


Aziz Mottiwala, Chief Commercial Officer, Tarsus Pharmaceuticals, Inc.

John Hovanesian, MD, FACS, Private Practice, Harvard Eye Associates, Laguna Hills, CA Clinical Faculty, UCLA Jules Stein Eye Institute, Los Angeles, CA 

11:25 – 12:00 pm PST


Private Equity: The Good, The Bad, The Ugly

Join our industry experts in hearing the latest information on what is happening with Private Equity. Learn about how it works, the existing challenges, and what we will see in

Richard Lindstrom, MD, Minnesota Eye Consultants (Moderator)

Farrel “Toby” Tyson, MD, FACS, Tyson Eye

Denise M. Visco, MD, MBA, Medical Director, Eyes of York

12:00 – 12:20 pm PST


Ramin Valian, Vice President-Eye Care and Pipeline Commercialization Strategy, AbbVie

Nicole Fram, MD, Managing Partner, Advanced Vision Care

12:20 – 12:30 pm PST


The Roger Steinert, MD Legacy Award Presented by The Gavin Herbert Eye Institute

Baruch Kuppermann, MD, PhD, Steinert Endowed Professor, Chair, Department of Ophthalmology, Director, Gavin Herbert Eye Institute, University of California, Irvine

12:30 – 1:10 pm PST


Lunch and Networking

1:10 – 2:30 pm PST


Capital & Growth Company Presentations

Emcee: Thomas Ruggia, President and CEO, Samsara Vision



Mayssa Attar, PhD, Head of Pharmaceuticals R&D, Bausch & Lomb

Tara Capalbo, General Manager, Ocular Surface Disease and Glaucoma

2:30 – 3:00 pm PST


The Investment Landscape

Andrew Stewart, President, Global Ophthalmic Pharmaceuticals, Bausch & Lomb (moderator)

Marty Waters, Partner, Wilson Sonsini

Jeffry Weinhuff, Founder & Managing Partner, Visionary Ventures

3:00 – 3:15 pm PST


Break: Exhibits & Networking

3:15 – 3:45 pm PST


The Changing Ophthalmic Practice

Industry and physician experts will discuss the latest in aesthetics, cash pay technologies, practice growth opportunities,  and upcoming elective trends in eye care.

Sheri Rowen, MD, FACS, NVision Eye Centers (Moderator)

Elad Kedar, CEO, Orasis Pharmaceuticals

Mark Kontos, MD, Empire Eye (RxSight, Inc.)

Marc Odrich, CMO, Lenz Therapeutics

3:45 – 4:15 pm PST


Join us, as top industry physicians debate the hottest topics in eye care! 


Patient Profile: What technology would you use?

Premium IOL’s/Dry Eye Protocols

4:15 – 4:45 pm PST


The Modern Ophthalmology Practice

AI is already changing our everyday lives. This session will feature a series of presentations by leading experts focusing on advancing AI, what it means to our industry, and its impact on surgical practices and patients.

Peter Menzisuo, Company Group Chairman, Johnson & Johnson Vision (Moderator)

4:45 – 5:15 pm PST


Interventional Glaucoma

Leading industry and surgeon glaucoma experts will present some of the leading innovations in glaucoma. Join us to discuss recent technology advancements and the changing reimbursement environment.

Shawn O’Neil, Chief Commercial Officer, ViaLase Inc.

Mitchell Shultz, MD, Medical Director, Shultz Chang Vision, Co-Founder and Chief Medical Officer, Alchemy Vision

Kuldev Singh, MD, MPH, Professor of Ophthalmology and Director of the Glaucoma Service, Stanford University

5:15 – 5:20 pm PST


Closing Comments

Bill Carpou, CEO, Octane

5:20 – 7:30 pm PST

Closing Reception
Saturday, June 22, 2024

6:45 – 11:45 am PST


Tier 1 Advisory Board Meetings

6:45 – 8:15 am

8:30 – 10:00 am (sold out)

10:15 – 11:45 am

Ophthalmology Tech Forum 2024

Newport Beach Marriott Hotel & Spa 900 Newport Center Drive, Newport Beach, CA, United States

At Ophthalmology Tech Forum, industry, key opinion leaders, and top ophthalmologists discuss the future of the industry. The event is held annually in Orange County, the center for Ophthalmology in […]

Women Leaders of Octane Quarterly Meeting (July 2024)


Please join Women Leaders of Octane for our virtual quarterly meeting, Wednesday, July 17 from 12 – 1 pm PST, featuring our Spotlight Thought Leader, Paige Hendrix Buckner, CEO of […]

Contact Us.




4041 MacArthur Blvd, Suite 260 Newport Beach, CA 92660


© 2024 Octane